File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong

TitleValidation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong
Authors
Keywordsalgorithms
bronchiectasis
EHR
electronic health record
validation
Issue Date11-May-2023
PublisherWiley
Citation
Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1077-1082 How to Cite?
Abstract

Background and Objective

Electronic medical record (EMR) databases can facilitate epidemiology research in various diseases including bronchiectasis. Given the diagnostic challenges of bronchiectasis, the validity of the coding in EMR requires clarification. We aimed to assess the validity of International Classification of Diseases, 9th Revision (ICD-9) code algorithms for identifying bronchiectasis in the territory-wide electronic medical health record system of Clinical Data Analysis and Reporting System (CDARS) in Hong Kong.

Materials and Methods

Adult patients who had the diagnosis of bronchiectasis input from Queen Mary Hospital in 2011–2020 were identified using the ICD-9 code of 494 by CDARS. All patients who had high resolution computed tomography (HRCT) were reviewed by respiratory specialists to confirm the presence of bronchiectasis on HRCT.

Results

A total of 19 617 patients who had the diagnostic code of bronchiectasis among all public hospitals in Hong Kong and 1866 in Queen Mary Hospital in the same period. Six hundred and forty-eight cases were randomly selected and validated using medical record and HRCT review by a respiratory specialist. The overall positive predictive value (PPV) was 92.7% (95% CI 90.7–94.7).

Conclusions

This was the first ICD-9 coding validation for bronchiectasis in Hong Kong CDARS. Our study demonstrated that using ICD-9 code of 494 was reliable to support utility of CDARS database for further clinical research on bronchiectasis.


Persistent Identifierhttp://hdl.handle.net/10722/339690
ISSN
2021 Impact Factor: 2.732
2020 SCImago Journal Rankings: 1.023

 

DC FieldValueLanguage
dc.contributor.authorKwok, Wang Chun-
dc.contributor.authorTam, Terence Chi Chun-
dc.contributor.authorSing, Chor Wing-
dc.contributor.authorChan, Esther Wai Yin-
dc.contributor.authorCheung, Ching‐Lung-
dc.date.accessioned2024-03-11T10:38:36Z-
dc.date.available2024-03-11T10:38:36Z-
dc.date.issued2023-05-11-
dc.identifier.citationPharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1077-1082-
dc.identifier.issn1053-8569-
dc.identifier.urihttp://hdl.handle.net/10722/339690-
dc.description.abstract<h3>Background and Objective</h3><p>Electronic medical record (EMR) databases can facilitate epidemiology research in various diseases including bronchiectasis. Given the diagnostic challenges of bronchiectasis, the validity of the coding in EMR requires clarification. We aimed to assess the validity of International Classification of Diseases, 9th Revision (ICD-9) code algorithms for identifying bronchiectasis in the territory-wide electronic medical health record system of Clinical Data Analysis and Reporting System (CDARS) in Hong Kong.</p><h3>Materials and Methods</h3><p>Adult patients who had the diagnosis of bronchiectasis input from Queen Mary Hospital in 2011–2020 were identified using the ICD-9 code of 494 by CDARS. All patients who had high resolution computed tomography (HRCT) were reviewed by respiratory specialists to confirm the presence of bronchiectasis on HRCT.</p><h3>Results</h3><p>A total of 19 617 patients who had the diagnostic code of bronchiectasis among all public hospitals in Hong Kong and 1866 in Queen Mary Hospital in the same period. Six hundred and forty-eight cases were randomly selected and validated using medical record and HRCT review by a respiratory specialist. The overall positive predictive value (PPV) was 92.7% (95% CI 90.7–94.7).</p><h3>Conclusions</h3><p>This was the first ICD-9 coding validation for bronchiectasis in Hong Kong CDARS. Our study demonstrated that using ICD-9 code of 494 was reliable to support utility of CDARS database for further clinical research on bronchiectasis.</p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofPharmacoepidemiology & Drug Safety-
dc.subjectalgorithms-
dc.subjectbronchiectasis-
dc.subjectEHR-
dc.subjectelectronic health record-
dc.subjectvalidation-
dc.titleValidation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong-
dc.typeArticle-
dc.identifier.doi10.1002/pds.5638-
dc.identifier.scopuseid_2-s2.0-85160824595-
dc.identifier.volume32-
dc.identifier.issue10-
dc.identifier.spage1077-
dc.identifier.epage1082-
dc.identifier.eissn1099-1557-
dc.identifier.issnl1053-8569-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats